Abstract: The disclosure relates generally to the field of immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. The disclosure also relates to anti-SARS-COV-2 antibodies that have been obtained from subjects who became immune to this coronavirus, and to methods of using these anti-SARS-COV-2 antibodies. Methods for neutralizing SARS-COV-2 are disclosed, as well treatments for SARS-COV-2 using the anti-SARS-COV-2 antibodies.

Abstract: The disclosure relates generally to the field of immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. The disclosure also relates to anti-SARS-CoV-2 antibodies that have been obtained from subjects who became immune to this coronavirus, and to methods of using these anti-SARS-CoV-2 antibodies. Methods for neutralizing SARS-CoV-2 are disclosed, as well treatments for SARS-COV-2 using the anti-SARS-CoV-2 antibodies.

Abstract: The disclosure relates generally to the field of immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. The disclosure also relates to anti-SARS-CoV-2 antibodies that have been obtained from subjects who became immune to this coronavirus, and to methods of using these anti-SARS-CoV-2 antibodies. Methods for neutralizing SARS-CoV-2 are disclosed, as well treatments for SARS-COV-2 using the anti-SARS-CoV-2 antibodies.

Abstract: A mounting apparatus includes a back plate, at least one lower receiving channel adjacent to a lower edge of the back plate and configured to receive a lower holding tab of a line-replaceable unit, at least one upper receiving channel adjacent to an upper edge of the back plate and configured to receive an upper holding tab of the line-replaceable unit, and at least one tensioning member configured to urge the lower holding tab and the upper holding tab into the at least one lower receiving channel and the at least one upper receiving channel, respectively.

Abstract: A mounting apparatus includes a back plate, at least one lower receiving channel adjacent to a lower edge of the back plate and configured to receive a lower holding tab of a line-replaceable unit, at least one upper receiving channel adjacent to an upper edge of the back plate and configured to receive an upper holding tab of the line-replaceable unit, and at least one tensioning member configured to urge the lower holding tab and the upper holding tab into the at least one lower receiving channel and the at least one upper receiving channel, respectively.

Abstract: Solid pigment concentrate comprising at least one pigment and a dispersant comprising a polyamine backbone and one or more hydrophobic pendent groups, characterized in that the concentrate further comprises a non-ionic 5 surface active agent comprising polyoxyalkylene groups. The polyamine backbone can for instance comprise polyalkylene imine building blocks.

Abstract: Solid pigment concentrate comprising at least one pigment and a dispersant comprising a polyamine backbone and one or more hydrophobic pendent groups, characterized in that the concentrate further comprises a non-ionic 5 surface active agent comprising polyoxyalkylene groups. The polyamine backbone can for instance comprise polyalkylene imine building blocks.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: A system includes a transmitter for receiving a software upgrade and transmitting a message that includes the software upgrade and a digital signature. A receiver receives the message, and authenticates the digital signature. In response to authentication of the digital signature, the receiver installs the software upgrade associated with the message transmitted by the transmitter.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: A method of automating a workflow includes transmitting, to a multifunction peripheral, information that identifies the name and a present state of the workflow at the multifunction peripheral. The method continues with accepting, by way of a user input to the multifunction peripheral, a modification to the workflow, and inserting the modification into the workflow at the multifunction peripheral.

Abstract: A digital transmitter detects a security code and determines whether a user of the digital transmitter has proper security authorization. The digital transmitter sends data corresponding to printed material scanned into the digital transmitter to one or more destination addresses selected by the user when the user has proper security authorization and implements security measures when the user does not have proper security authorization.

Abstract: Methods and apparatus for tracking a data file corresponding to printed material scanned into a digital transmitter are provided. A database is searched for a tracking number contained in the data file to determine whether the data file is stored in the database. A confirmation message is sent indicating that the data file has been stored in the database upon locating the tracking number. An error message is sent indicating that the data file has not been stored in the database when the tracking number cannot be found in the database.